1Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral dietary regimens on selected outcome variables in bum patients [ J ]. J Parenter Enteral Nutr, 1990,14 ( 3 ) : 225 - 236.
2Matsuda N, Hattofi Y. Systemic inflanunatory response syndrome (SIRS) : molecular pathophysiology and gene therapy [J]. J Phar- macol Sci,2006,101 (3) :189 - 198.
3Bone RC. Sir Isaac Newton,sepsis,SIRS,and CARS[J]. Crit Care Meal, 1996,24(7) :1125 - 1128.
4Berger MM, Chiolero RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome[ J ]. Crit Care Med,2007, 35(9 Suppl) :$584 -590.
5Heyland DK,Dhaliwal R, Suehner U, et al. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient [J]. Intensive Care Meal,2005,31 ( 3 ) :327 - 337.
6Giladi AM, Dossett LA, Fleming SB, et al. High-dose antioxidant administration is associated with a reduction in post-injury compli- cations in critically ill trauma patients[J]. Injury ,2011,42 (1) :78 - 82.
7Wischmeyer PE. Glutamine: mode of action in critical illness[ J]. Crit Care Med,2007,35(9 Suppl) :S541 -544.
8Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence[J]. Crit Care Med,2002,30 (9) :2022 - 2029.
9Bansal V, Ochoa JB. Arginine availability, Arginase, and the im- mune response [ J ]. Curt Opin Ctin Nutr Metab Care, 2003,6 (2) : 223 - 228.
10Chiarla C, Giovannini I, Siegel JH. Plasma Arginine correlations in trauma and sepsis[ J]. Amino Acids,2006,30( 1 ) :81 -86.
